- Filed
- May 12, 2025 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · May 9, 2025 | 18.04M sh |
| Long Term Debt | Q1 2025 · Mar 31, 2025 | $93.75M |
| Long Term Debt | Q1 2025 · Dec 31, 2024 | $93.42M |
| Short Term Debt | Q1 2025 · Mar 31, 2025 | $0 |
| Short Term Debt | Q1 2025 · Dec 31, 2024 | $0 |
| Cash And Equivalents | Q1 2025 · Mar 31, 2025 | $161.6M |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $131.93M |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $83.43M |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $79.16M |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $268.65M |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $266.22M |
| Current Assets | Q1 2025 · Mar 31, 2025 | $272.51M |
| Current Assets | Q1 2025 · Dec 31, 2024 | $260.57M |
| Total Assets | Q1 2025 · Mar 31, 2025 | $578.66M |
| Total Assets | Q1 2025 · Dec 31, 2024 | $570.1M |
| Shares Diluted | Q1 2025 · Mar 31, 2024 | 17.81M sh |
| Stock Repurchased | Q1 2025 · Mar 31, 2024 | $4.11M |
| Capex | Q1 2025 · Mar 31, 2024 | $6.22M |
| Operating Cash Flow | Q1 2025 · Mar 31, 2024 | $20.74M |
| Stockholders Equity | Q1 2025 · Mar 31, 2024 | $288.47M |
| Stockholders Equity | Q1 2025 · Dec 31, 2023 | $291.98M |
| Eps Diluted | Q1 2025 · Mar 31, 2024 | −$0.06 |
| Eps Basic | Q1 2025 · Mar 31, 2024 | −$0.06 |
| Sga Expense | Q1 2025 · Mar 31, 2024 | $36.28M |
| Net Income | Q1 2025 · Mar 31, 2024 | $516K |
| Operating Income | Q1 2025 · Mar 31, 2024 | $5.18M |
| Cost Of Revenue | Q1 2025 · Mar 31, 2024 | $72.43M |
| Revenue | Q1 2025 · Mar 31, 2024 | $154.43M |